Penumbra, Inc. (PEN): Price and Financial Metrics
PEN Price/Volume Stats
| Current price | $186.94 | 52-week high | $282.11 |
| Prev. close | $200.01 | 52-week low | $148.00 |
| Day low | $186.78 | Volume | 601,100 |
| Day high | $200.01 | Avg. volume | 385,897 |
| 50-day MA | $188.92 | Dividend yield | N/A |
| 200-day MA | $215.68 | Market Cap | 7.25B |
PEN Stock Price Chart Interactive Chart >
Penumbra, Inc. (PEN) Company Bio
Penumbra Inc. is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. The company was founded in 2004 and is based in Alameda, CA.
Latest PEN News From Around the Web
Below are the latest news stories about PENUMBRA INC that investors may wish to consider to help them evaluate PEN as an investment opportunity.
5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue their strong performance in 2024. |
Penumbra (PEN) Stock Up 16.2% YTD: Will the Rally Continue?Investors are optimistic about Penumbra (PEN), driven by growth in the vascular segments and upbeat guidance. |
Is Penumbra (PEN) a Good Short Position?Diamond Hill Capital, an investment management company, released its “Long-Short Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The positive returns of the portfolio outperformed the Russell 1000 Index and the blended benchmark (60% Russell 1000 Index/40% Bloomberg US Treasury Bills 1-3 Month Index), both of which were negative in […] |
Here's Why You Should Invest in Penumbra (PEN) Stock NowInvestors are optimistic about Penumbra (PEN), which is led by growth in vascular and neuro businesses. |
Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare ConferencePenumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the J.P. Morgan 42nd Annual Healthcare Conference on Monday, January 8, 2024. |
PEN Price Returns
| 1-mo | -1.23% |
| 3-mo | -0.45% |
| 6-mo | -20.23% |
| 1-year | -30.14% |
| 3-year | -35.29% |
| 5-year | 23.43% |
| YTD | -25.68% |
| 2023 | 13.07% |
| 2022 | -22.57% |
| 2021 | 64.18% |
| 2020 | 6.53% |
| 2019 | 34.43% |
Continue Researching PEN
Here are a few links from around the web to help you further your research on Penumbra Inc's stock as an investment opportunity:Penumbra Inc (PEN) Stock Price | Nasdaq
Penumbra Inc (PEN) Stock Quote, History and News - Yahoo Finance
Penumbra Inc (PEN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...